Changes In Primary Blasts Of Aml Patients Treated With Decitabine And
Changes in primary blasts of AML patients treated with decitabine and ...
Enrollment and outcomes. 91 AML patients were treated with decitabine ...
Prognostic impact of MLL5 expression in AML patients treated with ...
Survival of adult AML patients treated with chemotherapy in the U.S ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Enrollment and outcomes in patients with decitabine treatment ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Induction of gene expression in primary AML and MDS but not in normal ...
Advertisement Space (300x250)
Odds ratio of decitabine response in AML patients according to age ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Enrollment and outcomes in patients with decitabine treatment ...
HDAC1/2 inhibition suppresses AML cells in vitro and primary AML blasts ...
| Primary AML blasts cultured ex vivo were treated with increasing ...
Schematic representation of cellular and metabolic changes in adult AML ...
| Primary AML blasts cultured ex vivo were treated with increasing ...
DQA and embelin treatment induces cell death in AML primary blasts by ...
Phase I/II study of dasatinib in combination with decitabine in ...
| Cell growth and apoptosis of primary AML blasts. (A,B) Primary AML ...
Advertisement Space (336x280)
In vivo antileukemic activity of ATRA in cell line model and primary ...
| Cell growth and apoptosis of primary AML blasts. (A,B) Primary AML ...
Phase I/II study of dasatinib in combination with decitabine in ...
A phase 2 study of decitabine with or without carboplatin and arsenic ...
Pretransplantation MRD in Older Patients With AML After Treatment With ...
| Cell growth and apoptosis of primary AML blasts. (A,B) Primary AML ...
Emetine induced cell death in AML primary blasts sparing healthy blood ...
Evidence of target inhibition in AML blasts a,b, Change in baseline (a ...
Treatment of primary cells of de novo AML with the HCK inhibitor ...
Pretransplantation MRD in Older Patients With AML After Treatment With ...
Advertisement Space (336x280)
Dasatinib and decitabine treatment for patients with accelerated or ...
Phase I trial of plerixafor combined with decitabine in newly diagnosed ...
Effects of decitabine (DAC) 0.5 μM (full lines) and vehicle treatment ...
Enhancing cytotoxicity of immunotoxins in AML | Blood | American ...
Genomic impact of transient low-dose decitabine treatment on primary ...
In vivo kinetics of early, non-random methylome and transcriptome ...